By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Santen Pharmaceutical Co., Ltd. 

3-9-19 Shimo-Shinjo Higashi Yodogawa-ku

Osaka    533  Japan
Phone: 81-0-6-3217000 Fax: 81-0-6-3285082


SEARCH JOBS


Industry
Pharmaceutical






Company News
Santen Pharmaceutical Reports Consolidated Performance For The Fiscal Year Ended March 31, 2015 5/12/2015 8:23:08 AM
Santen Pharmaceutical Announces Assignment Of Its Anti-Rheumatic Pharmaceuticals Business To Hyperion Pharma 5/12/2015 7:34:13 AM
R-Tech Ueno: Announcement On Acquisition Of The Right To Develop And Commercialize DE-105 From Santen Pharmaceutical 4/27/2015 10:54:10 AM
Santen Pharmaceutical Announces Approval Of Ikervis For EU Marketing Authorization 3/25/2015 8:00:04 AM
Santen Pharmaceutical Release: Increase Of Capital For A Consolidated Subsidiary In Europe 9/25/2014 7:55:10 AM
Santen Pharmaceutical Facilitates Compliance, Promotes Safety, And Supports Growth With Oracle (ORCL) Argus Cloud Service 7/9/2014 2:10:24 PM
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014 6:40:49 AM
Santen Pharmaceutical And TRACON Pharmaceuticals, Inc. Announce Agreement For The Development And Commercialization Of TRC105 In Ophthalmology 3/4/2014 11:38:33 AM
Santen Pharmaceutical Announces the Appointment of Naveed Shams, M.D., Ph.D. as the President and CEO 3/12/2013 9:39:52 AM
Santen Pharmaceutical and Clearside Biomedical Enter Into Financing and Research Collaboration Agreements for Posterior Ocular Disease 1/31/2013 10:18:08 AM
123
//-->